Lab-grown models that recreate and test early human cortex development

Platform to accurately recapitulate and perturb cortical development and morphogenesis in vitro

NIH-funded research Harvard University · NIH-11230239

This project grows and tweaks human tissue models of the developing brain to learn which genes and signals cause early cortical malformations and help people with developmental brain disorders.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHarvard University NIH-funded
Lab location1 site (Cambridge, United States)
Project IDNIH-11230239 on NIH RePORTER

What this research studies

Scientists will turn human stem cells into organized forebrain-like tissues using bioengineering methods such as printed cysts and controlled signaling gradients. They will apply high-throughput, cell-type specific genetic perturbations and use single-cell genomics plus advanced imaging to watch how cells form patterns and shapes. The platform is built to test hundreds of conditions in parallel to identify genes and signals that drive normal versus abnormal cortical morphogenesis. Findings aim to clarify mechanisms behind congenital brain malformations and point toward better diagnostics and treatments.

Who could benefit from this research

Good fit: People or families affected by congenital cortical malformations or with known mutations in developmental genes (for example BMPR1A or ACVRLK3) could be candidates to provide samples or be future beneficiaries of this research.

Not a fit: People with adult-acquired neurological conditions that are unrelated to early brain development are unlikely to receive direct benefit from this specific project.

Why it matters

Potential benefit: If successful, this work could reveal genetic and developmental causes of early brain malformations and speed development of improved diagnostics and targeted therapies.

How similar studies have performed: Organoid and stem-cell models have previously captured some aspects of human brain development, but combining high-throughput patterning with large-scale genetic perturbations is a newer and less-tested approach.

Where this research is happening

Cambridge, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.